Clinical ArticleFetal Intervention During the COVID-19 PandemicWilpers, Abigail PhD, WHNP-BC; Eichhorn, Barbara BSN, RN; Vermeersch, Leslie RN, ARDMS, BKin, BScN; Gosnell, Kristen MS, RNAuthor Information Abigail Wilpers, PhD, WHNP-BC Maternal-Fetal Health Postdoctoral Research Associate, Department of Obstetrics, Gynecology & Reproductive Sciences, Yale School of Medicine, and Fetal Therapy Nurse, The Fetal Care Center of Yale New Haven Hospital, New Haven, CT. Barbara Eichhorn, BSN, RN Nurse Coordinator, Center for Advanced Fetal Diagnostics & Center for Innovative Fetal Intervention, University of Pittsburgh Medical Center, Magee-Womens Hospital, Pittsburgh, PA. Leslie Vermeersch, RN, ARDMS, BKin, BScN Fetal Therapy Coordinator, Ontario Fetal Centre, Mount Sinai Hospital, Toronto, Ontario, Canada. Kristen Gosnell, MS, RN Research Nurse, The Fetal Treatment Center, University of California, San Francisco, San Francisco, CA. The authors have declared no conflict of interest. Correspondence: Abigail Wilpers, PhD, WHNP-BC, Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, 1 Long Wharf Drive, New Haven, CT 06511. E-mail: email@example.com Journal of Pediatric Surgical Nursing: 7/9 2020 - Volume 9 - Issue 3 - p 111-114 doi: 10.1097/JPS.0000000000000263 Buy Metrics Abstract Two case studies are presented that illustrate the challenges of fetal diagnosis and intervention during the COVID-19 pandemic. Clinical recommendations from the North American Fetal Therapy Network and the International Fetal Medicine and Surgery Society are reviewed. Finally, the experiences and actions of nurses practicing in fetal intervention during the COVID-19 pandemic are illustrated through a discussion of the ongoing Fetal Therapy COVID-19 Survey. Copyright © 2020 American Pediatric Surgical Nursing Association, Inc.